PhD student to Nanyang Technological University (August 2025)
6430
PI (Chen Peng) is a professor of bioengineering in School of Chemistry, Chemical Engineering and Biotechnology (CCEB), Lee Kong Chian School of Medicine, and Institute of Digital Molecular Analytics and Sciences (IDMxS) at NTU. He is also the chief engineer for Skin Research Institute of Singapore. He is recruiting PhD student for the August 2025 intake.
Currently, his group is actively researching on:
1) Bioengineering approaches to combat chronic diseases such as obesity and other metabolic diseases (e.g., https://www.straitstimes.com/singapore/health/new-therapy-to-tackle-obesity-by-ntu-team-uses-gel-and-infrared-light-safety-shown-in-trials-on-mice )
2) Advanced theranostic technologies which involve both targeted drug delivery (e.g., Sights set on more effective way to treat eye diseases, SATURDAY, DECEMBER 1, 2018 | THE STRAITS TIMES) and detection of biomarkers for skin disorders, cancers, etc.
3) Developing digital molecular analytical technologies which may transform the current diagnosis practices with ultrahigh sensitivity and multiplexed assays based on a tiny-volume sample.
4) Flexible devices for wearable or implantable biomedical applications based on conducting polymers, hydrogels, and other soft matters.
5) Nanomaterials (e.g., graphene, Mxene, metal-organic-frameworks) & applications (e.g., biosensing, imaging, therapy, catalysis).
For enquiry or discussion, please contact Prof. Chen Peng at 1point3acres.com
Currently, his group is actively researching on:
1) Bioengineering approaches to combat chronic diseases such as obesity and other metabolic diseases (e.g., https://www.straitstimes.com/singapore/health/new-therapy-to-tackle-obesity-by-ntu-team-uses-gel-and-infrared-light-safety-shown-in-trials-on-mice )
2) Advanced theranostic technologies which involve both targeted drug delivery (e.g., Sights set on more effective way to treat eye diseases, SATURDAY, DECEMBER 1, 2018 | THE STRAITS TIMES) and detection of biomarkers for skin disorders, cancers, etc.
3) Developing digital molecular analytical technologies which may transform the current diagnosis practices with ultrahigh sensitivity and multiplexed assays based on a tiny-volume sample.
4) Flexible devices for wearable or implantable biomedical applications based on conducting polymers, hydrogels, and other soft matters.
5) Nanomaterials (e.g., graphene, Mxene, metal-organic-frameworks) & applications (e.g., biosensing, imaging, therapy, catalysis).
For enquiry or discussion, please contact Prof. Chen Peng at 1point3acres.com
0条回复